Published in Pacing Clin Electrophysiol on March 25, 2014
Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study. Eur Heart J (2015) 1.62
Sensing and detection in Medtronic implantable cardioverter defibrillators. Herzschrittmacherther Elektrophysiol (2016) 0.78
Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke (2012) 2.64
Benefit of immediate beta-blocker therapy on mortality in patients with ST-segment elevation myocardial infarction. Crit Care Med (2013) 2.64
Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial. J Am Coll Cardiol (2008) 2.18
Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study. J Cardiovasc Electrophysiol (2009) 2.14
Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol (2008) 2.10
Atrial response to ventricular antitachycardia pacing discriminates mechanism of 1:1 atrioventricular tachycardia. J Cardiovasc Electrophysiol (2005) 2.10
Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J (2008) 1.83
Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model. Cardiovasc Res (2011) 1.76
Discrimination of ventricular tachycardia from supraventricular tachycardia by a downloaded wavelet-transform morphology algorithm: a paradigm for development of implantable cardioverter defibrillator detection algorithms. J Cardiovasc Electrophysiol (2002) 1.65
Genetic suppression of atrial fibrillation using a dominant-negative ether-a-go-go-related gene mutant. Heart Rhythm (2011) 1.59
beta3-Adrenergic regulation of an ion channel in the heart-inhibition of the slow delayed rectifier potassium current I(Ks) in guinea pig ventricular myocytes. Cardiovasc Res (2002) 1.44
Impact of structural heart disease on the acute complication rate in atrial fibrillation ablation: results from the German Ablation Registry. J Cardiovasc Electrophysiol (2013) 1.43
Anti-KCNQ1 K⁺ channel autoantibodies increase IKs current and are associated with QT interval shortening in dilated cardiomyopathy. Cardiovasc Res (2013) 1.40
Human histopathology of electroanatomic mapping after cooled-tip radiofrequency ablation to treat ventricular tachycardia in remote myocardial infarction. J Cardiovasc Electrophysiol (2005) 1.29
Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry. Europace (2010) 1.26
EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace (2010) 1.25
Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death. Heart Rhythm (2007) 1.24
Intracardiac impedance monitors hemodynamic deterioration in a chronic heart failure pig model. J Cardiovasc Electrophysiol (2007) 1.15
Molecular mechanisms of early electrical remodeling: transcriptional downregulation of ion channel subunits reduces I(Ca,L) and I(to) in rapid atrial pacing in rabbits. J Am Coll Cardiol (2003) 1.11
Identification of nestin-positive putative mammary stem cells in human breastmilk. Cell Tissue Res (2007) 1.03
[Health care quality: medication and prevention in patients with and without coronary heart disease]. Med Klin (Munich) (2004) 1.02
Altered HCN4 channel C-linker interaction is associated with familial tachycardia-bradycardia syndrome and atrial fibrillation. Eur Heart J (2012) 1.01
MolLoc: a web tool for the local structural alignment of molecular surfaces. Nucleic Acids Res (2009) 1.01
Safe performance of magnetic resonance of the heart in patients with magnetic resonance conditional pacemaker systems: the safety issue of the ESTIMATE study. J Cardiovasc Magn Reson (2014) 0.98
Catheter ablation of electrical storm in a collaborative hospital network. Am J Cardiol (2011) 0.95
Workload and usefulness of daily, centralized home monitoring for patients treated with CIEDs: results of the MoniC (Model Project Monitor Centre) prospective multicentre study. Europace (2012) 0.94
Discovery of similar regions on protein surfaces. J Comput Biol (2007) 0.94
Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot study. Eur Heart J (2011) 0.94
cAMP sensitivity of HCN pacemaker channels determines basal heart rate but is not critical for autonomic rate control. Circ Arrhythm Electrophysiol (2010) 0.93
A randomized controlled trial of secondary prevention of anxiety and distress in a German sample of patients with an implantable cardioverter defibrillator. Psychosom Med (2010) 0.92
Left atrial versus bi-atrial Maze operation using intraoperatively cooled-tip radiofrequency ablation in patients undergoing open-heart surgery: safety and efficacy. J Am Coll Cardiol (2002) 0.92
Biological Heart Rate Reduction Through Genetic Suppression of Gα(s) Protein in the Sinoatrial Node. J Am Heart Assoc (2012) 0.92
Form analysis using digital signal processing reliably discriminates far-field R waves from P waves. Pacing Clin Electrophysiol (2004) 0.91
Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation. Drug Des Devel Ther (2011) 0.89
Long-term sinus rhythm stability after intraoperative ablation of permanent atrial fibrillation. Pacing Clin Electrophysiol (2009) 0.89
Effective labeling of molecular surface points for cavity detection and location of putative binding sites. Comput Syst Bioinformatics Conf (2007) 0.89
Intra-operative cooled-tip radiofrequency linear atrial ablation to treat permanent atrial fibrillation. Eur Heart J (2007) 0.89
Activating transcription factor 2 controls Bcl-2 promoter activity in growth plate chondrocytes. J Cell Biochem (2007) 0.88
Initial experience with robotic navigation for catheter ablation of paroxysmal and persistent atrial fibrillation. J Electrocardiol (2011) 0.88
One-year results of transcatheter aortic valve implantation in severe symptomatic aortic valve stenosis. Am J Cardiol (2011) 0.87
PKC-dependent activation of human K(2P) 18.1 K(+) channels. Br J Pharmacol (2012) 0.87
Successful acute and long-term management of electrical storm in Brugada syndrome using orciprenaline and quinine/quinidine. Clin Res Cardiol (2010) 0.87
Monocenter feasibility study of the MRI compatibility of the Evia pacemaker in combination with Safio S pacemaker lead. J Cardiovasc Magn Reson (2012) 0.86
Assessing acute ventricular volume changes by intracardiac impedance in a chronic heart failure animal model. Pacing Clin Electrophysiol (2009) 0.85
Catheter ablation of electrical storm. Expert Rev Cardiovasc Ther (2011) 0.85
Long-term experience with subcutaneous ICD leads: a comparison among three different types of subcutaneous leads. Pacing Clin Electrophysiol (2004) 0.84
[Quality of antithrombotic therapy in patients with chronic atrial fibrillation: the AFib Trial]. Z Arztl Fortbild Qualitatssich (2003) 0.84
Study design of the man and machine trial: a prospective international controlled noninferiority trial comparing manual with robotic catheter ablation for treatment of atrial fibrillation. J Cardiovasc Electrophysiol (2012) 0.83
Shift in the pattern of autonomic atrial innervation in subjects with persistent atrial fibrillation. Heart Rhythm (2011) 0.83
Genetic suppression of Gαs protein provides rate control in atrial fibrillation. Basic Res Cardiol (2012) 0.83
A multicenter study of shock pathways for subcutaneous implantable defibrillators. J Cardiovasc Electrophysiol (2013) 0.83
Alternative splicing determines mRNA translation initiation and function of human K(2P)10.1 K+ channels. J Physiol (2011) 0.82
How good are experienced interventional cardiologists at predicting the functional significance of intermediate or equivocal left main coronary artery stenoses? Int J Cardiol (2007) 0.81
Identification and functional characterization of zebrafish K(2P)10.1 (TREK2) two-pore-domain K(+) channels. Biochim Biophys Acta (2011) 0.80
Electrocardiographic events preceding onset of atrial fibrillation: insights gained using an implantable loop recorder. J Cardiovasc Electrophysiol (2006) 0.80
Mortality of patients with implanted cardioverter/defibrillators in relation to episodes of atrial fibrillation. Europace (2004) 0.80
Acute and long-term clinical significance of myocardial contusion following blunt thoracic trauma: results of a prospective study. J Trauma (2002) 0.80
In vitro modulation of HERG channels by organochlorine solvent trichlormethane as potential explanation for proarrhythmic effects of chloroform. Toxicol Lett (2006) 0.79
Unexplained syncope: implications of age and gender on patient characteristics and evaluation, the diagnostic yield of an implantable loop recorder, and the subsequent treatment. Clin Cardiol (2014) 0.79
Early versus delayed implantation of a loop recorder in patients with unexplained syncope--effects on care pathway and diagnostic yield. Int J Cardiol (2013) 0.78
Impaired ion channel function related to a common KCNQ1 mutation - implications for risk stratification in long QT syndrome 1. Gene (2012) 0.78
Atrial fibrillation--rate versus rhythm control. N Engl J Med (2003) 0.78
Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K(+) (K2 ₂p) channels. Eur J Pharmacol (2013) 0.78
Stability and cause of anxiety in patients with an implantable cardioverter-defibrillator: a longitudinal two-year follow-up. Heart Lung (2007) 0.78
Functional characterization of zebrafish K2P18.1 (TRESK) two-pore-domain K+ channels. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.78
Therapeutic hypothermia after cardiac arrest in Lower Austria--a cross-sectional survey. Eur J Emerg Med (2011) 0.77
Patient-tailored implantable cardioverter defibrillator testing using the upper limit of vulnerability: the TULIP protocol. Europace (2008) 0.77
Biophysical properties of mutant KCNQ1 S277L channels linked to hereditary long QT syndrome with phenotypic variability. Biochim Biophys Acta (2011) 0.77
Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.77
Identification and functional characterization of the novel human ether-a-go-go-related gene (hERG) R744P mutant associated with hereditary long QT syndrome 2. Biochem Biophys Res Commun (2012) 0.77
Effects of the chromanol HMR 1556 on potassium currents in atrial myocytes. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.77
Enhancement of K2P2.1 (TREK1) background currents expressed in Xenopus oocytes by voltage-gated K+ channel β subunits. Life Sci (2012) 0.77
Anxiety disorders in patients with implantable cardioverter defibrillators: frequency, course, predictors, and patients' requests for treatment. Pacing Clin Electrophysiol (2013) 0.76
Efficacy of metoprolol and sotalol in the prevention of recurrences of sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Pacing Clin Electrophysiol (2002) 0.76
Effects of β-blocker therapy on electrocardiographic and echocardiographic characteristics of left ventricular noncompaction. Clin Res Cardiol (2014) 0.76
Radiation therapy-induced electrical reset of an implantable cardioverter defibrillator device located outside the irradiation field. J Electrocardiol (2004) 0.76
Bleeding complications associated with glycoprotein IIb/IIIa inhibitors in patients 80 years of age and older undergoing percutaneous coronary intervention. Exp Clin Cardiol (2010) 0.75
The relationship between pacing site and induction or termination of sustained monomorphic ventricular tachycardia by antitachycardia pacing. Pacing Clin Electrophysiol (2009) 0.75
Postinterventional medication after catheter ablation of atrial fibrillation: angiotensin receptor blockers or ACE inhibitors? Expert Rev Cardiovasc Ther (2007) 0.75
Catheter ablation of regular atrial arrhythmia following surgical treatment of permanent atrial fibrillation. J Cardiovasc Electrophysiol (2006) 0.75
Non-invasive determination of the optimized atrioventricular delay in patients with implanted biventricular pacing devices. Indian Pacing Electrophysiol J (2010) 0.75
Images in cardiovascular medicine. Follow-up of cardiac sarcoidosis by magnetic resonance imaging. Circulation (2005) 0.75
Inhibition of cardiac Kir2.1-2.3 channels by beta3 adrenoreceptor antagonist SR 59230A. Biochem Biophys Res Commun (2012) 0.75
Clinical and angiographic results of coronary artery stenting using PURA-VARIO (PUVA) stents. Int J Cardiovasc Intervent (2003) 0.75
[Remodeling in atrial fibrillation]. Herz (2002) 0.75
Hope for the best--plan for the worst: disaster preparedness in a strange new world. Mich Health Hosp (2003) 0.75
Prehospital treatment of patients with acute myocardial infarction with bivalirudin. Am J Emerg Med (2010) 0.75
Impact of dual chamber pacing on the incidence of atrial and ventricular tachyarrhythmias in recipients of implantable cardioverter defibrillators. Pacing Clin Electrophysiol (2005) 0.75
Monitoring of physical activity and heart rate variability in patients with chronic heart failure using cardiac resynchronization devices. Am J Cardiol (2005) 0.75
Usefulness of a limited linear ablation of post-myocardial infarction ventricular tachycardia using a standardized approach based on sinus rhythm mapping. Am J Cardiol (2010) 0.75
Electrophysiological findings in Fabry cardiomyopathy: mapping the maze of risk stratification. Acta Cardiol (2012) 0.75
Prognostic significance of atrial arrhythmias in a primary prevention ICD population. Pacing Clin Electrophysiol (2011) 0.75